Skip to main content
. 2017 Sep 18;17:145. doi: 10.1186/s12874-017-0424-3

Table 3.

Cross tabulation of respondents’ recommendation to the research ethics committee (REC) and personal preferences

Variable Overall, % (n = 338) Drug pRCT,
%
Dose-timing pRCT,
%
Written consent vs General notification (n = 85) Written consent vs Verbal consent (n = 85) Written consent vs General notification (n = 85) Written consent vs Verbal consent (n = 83)
Recommended written consent, preferred written consent 70.4 62.4 81.2 51.8 86.7
Recommended written consent, preferred alternative option 3.8 5.9 1.2 8.2 0.0
Recommended alternative option, preferred written consent 3.6 7.1 3.5 3.5 0.0
Recommended alternative option, preferred alternative option 22.2 24.7 14.1 36.5 13.3
p = 0.042 p < 0.001
Same personal preference and recommendation to the REC (Consistent responses) 92.6 87.1 95.3 88.3 100.0
p = 0.051 = 0.001
Personal preference and/or recommendation alternative option 92.6 37.6 18.8 48.2 17.3
p = 0.005 p < 0.001

pRCT pragmatic randomized controlled trial